The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells (Q38984993)

8 September 2017

The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells (English)

1 reference

8 September 2017

1 reference

1 reference

Weicheng Yao

1

1 reference

8 September 2017

Guocai Guo

2

1 reference

8 September 2017

Quanqin Zhang

3

1 reference

8 September 2017

Lingyan Fan

4

1 reference

8 September 2017

Ning Wu

5

1 reference

8 September 2017

Yongli Bo

6

1 reference

8 September 2017

language of work or name

English

0 references

publication date

8 May 2014

1 reference

8 September 2017

1 reference

8 September 2017

458-459

1 reference

8 September 2017

69-82

1 reference

NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Extensive modulation of a set of microRNAs in primary glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Integrated analysis of mRNA and microRNA expression in mature neurons, neural progenitor cells and neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Identification and functional characterization of microRNAs involved in the malignant progression of gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

MiRNA-451 plays a role as tumor suppressor in human glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Replicative oncolytic adenoviruses in multimodal cancer regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Clinical trial end points for high-grade glioma: the evolving landscape.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Regulation of miRNA expression during neural cell specification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Role of microRNA-26b in glioma development and its mediated regulation on EphA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

CEA promoter-regulated oncolytic adenovirus-mediated Hsp70 expression in immune gene therapy for pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

MicroRNA-mediated conversion of human fibroblasts to neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

The oncolytic adenovirus targeting to TERT and RB pathway induced specific and potent anti-tumor efficacy in vitro and in vivo for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.04.007

10.1016/J.VIROL.2014.04.007

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference